JBM's Subsidiaries to Sell 20% Stake in Chinese Medicine Subsidiary to Jacobson Pharma Unit

MT Newswires Live11-12

JBM's (Healthcare) (HKG:2161) subsidiaries Po Chai Herbal Technology and PCHT Herbal Sciences agreed to sell a 20% stake in Li Chung Shing Tong to Europharm Laboratoires, a subsidiary of Jacobson Pharma (HKG:2633), for HK$46.2 million, a Tuesday Hong Kong bourse filing said.

Li Chung Shing Tong is a Chinese medicine producer and distributor with HK$132.5 million in assets as of Oct. 31.

Upon completion of the deal, Po Chai Herbal will still own 43.9% of the total issued shares of Li Chung Shing Tong, and the target company will remain a subsidiary of JBM.

JBM plans to use the net proceeds of HK$46 million for the general working capital of the group.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2482744401?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-12 14:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2482744401","market":"us","top_or_hot":-1,"title":"JBM's Subsidiaries to Sell 20% Stake in Chinese Medicine Subsidiary to Jacobson Pharma Unit","media":"MT Newswires Live","content":"<html><body><p> JBM's (Healthcare) (HKG:2161) subsidiaries Po Chai Herbal Technology and PCHT Herbal Sciences agreed to sell a 20% stake in Li Chung Shing Tong to Europharm Laboratoires, a subsidiary of Jacobson Pharma (HKG:2633), for HK$46.2 million, a Tuesday Hong Kong bourse filing said.</p><p>Li Chung Shing Tong is a Chinese medicine producer and distributor with HK$132.5 million in assets as of Oct. 31.</p><p>Upon completion of the deal, Po Chai Herbal will still own 43.9% of the total issued shares of Li Chung Shing Tong, and the target company will remain a subsidiary of JBM.</p><p>JBM plans to use the net proceeds of HK$46 million for the general working capital of the group.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JBM's Subsidiaries to Sell 20% Stake in Chinese Medicine Subsidiary to Jacobson Pharma Unit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJBM's Subsidiaries to Sell 20% Stake in Chinese Medicine Subsidiary to Jacobson Pharma Unit\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-12 14:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>JBM's (Healthcare) (HKG:2161) subsidiaries Po Chai Herbal Technology and PCHT Herbal Sciences agreed to sell a 20% stake in Li Chung Shing Tong to Europharm Laboratoires, a subsidiary of Jacobson ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1606","symbol_name":"中医药概念","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2482744401","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2482744401","pubTimestamp":1731393060,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"JBM's   subsidiaries Po Chai Herbal Technology and PCHT Herbal Sciences agreed to sell a 20% stake in Li Chung Shing Tong to Europharm Laboratoires, a subsidiary of Jacobson Pharma , for HK$46.2 million, a Tuesday Hong Kong bourse filing said.Li Chung Shing Tong is a Chinese medicine producer and distributor with HK$132.5 million in assets as of Oct. 31.Upon completion of the deal, Po Chai Herbal will still own 43.9% of the total issued shares of Li Chung Shing Tong, and the target company will remain a subsidiary of JBM.JBM plans to use the net proceeds of HK$46 million for the general working capital of the group.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1606":"中医药概念","02161":"健倍苗苗","02633":"雅各臣科研制药","BK1191":"制药"},"translate_title":"JBM子公司将向雅各布森制药子公司出售中药子公司20%股权","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02633":1,"02161":0.9},"content_text":"JBM's (Healthcare) (HKG:2161) subsidiaries Po Chai Herbal Technology and PCHT Herbal Sciences agreed to sell a 20% stake in Li Chung Shing Tong to Europharm Laboratoires, a subsidiary of Jacobson Pharma (HKG:2633), for HK$46.2 million, a Tuesday Hong Kong bourse filing said.Li Chung Shing Tong is a Chinese medicine producer and distributor with HK$132.5 million in assets as of Oct. 31.Upon completion of the deal, Po Chai Herbal will still own 43.9% of the total issued shares of Li Chung Shing Tong, and the target company will remain a subsidiary of JBM.JBM plans to use the net proceeds of HK$46 million for the general working capital of the group.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2482744401"}